For the year ending 2025-12-31, IDYA made $218,710K in revenue. -$112,243K in net income. Net profit margin of -51.32%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 218,710 | |||
| Research and development | 314,704 | |||
| General and administrative | 63,319 | |||
| Total operating expenses | 378,023 | |||
| Loss from operations | -159,313 | |||
| Interest income and other income, net | 45,615 | |||
| Net loss | -113,698 | |||
| Unrealized gains on marketable securities | 1,455 | |||
| Comprehensive loss | -112,243 | |||
| Net loss per share attributable to common stockholders, basic | -1.28 | |||
| Net loss per share attributable to common stockholders, diluted | -1.28 | |||
| Weighted-average number of common shares outstanding used in computing net loss per share, basic | 88,485,238 | |||
| Weighted-average shares used in computing net loss per share attributable to common stock, diluted | 88,485,238 | |||
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)